Will RFK Jr.’s push for psychedelics help or hurt the emerging field?
Veterans groups are among those seeking to access the drug ibogaine and other psychedelics to treat PTSD, opioid addiction and other conditions.
By Matthew Perrone
Latest ""
DOD commits $9.8 million to study psychedelics for active-duty troops
During one study, physicians at Walter Reed plan to give the psychedelic drug MDMA to active-duty soldiers with mild to moderate PTSD.
By Noah Daly
Psychedelic therapy sparks clash between Colorado officials and vets
Amid psychedelic therapy's legalization in Colorado, veterans implored Colorado Springs officials not to pass treatment restrictions.
VA awards $1.5 million to study using psychedelics for PTSD treatment
The move is the first time Veterans Affairs leaders have funded a study into psychedelic benefits since the 1960s.
FDA rejects psychedelic MDMA as treatment for PTSD
MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.
By Matthew Perrone
Veterans push for psychedelic therapy, but MDMA application struggles
Veterans have spent years lobbying for the use of psychedelic drugs to treat PTSD, but a critical review of MDMA has put the therapy's approval in doubt.
By Matthew Perrone